Research-backed reference

Every peptide,
decoded clearly.

Clean, structured profiles for every compound, benefits, dosing, cycles, half-life, injection route, and side effects. Ranked by effectiveness within each category.

121

Compounds

17

Categories

Ranked

By efficacy

Browse the peptide index

121 compounds

MetabolicEmerging research

5-Amino-1MQ

5-Amino-1-Methylquinolinium

  • Explored for supporting increased energy expenditure in fat cells
  • Studied for potential fat-mass reduction in obesity research models

Morning

Dose

50-150 mg

Route

Oral

Weight BlendsEmerging research

5-Amino-1MQ / SLU-PP-332 Blend

5-Amino/SLU Blend · 1MQ-SLU-PP-332 Stack

  • 5-Amino-1MQ is studied for potential effects on adipocyte metabolism and body composition
  • SLU-PP-332 is described in preclinical rodent studies as mimicking some metabolic effects of endurance exercise

Morning

Dose

25-100 mg

Route

SubQ

MuscleModerate evidence

ACE-031

ACVR2B-Fc · RAP-031

  • Documented increases in lean muscle mass in early-phase human trials
  • Broad-spectrum trapping of multiple myostatin-family ligands

Morning

Dose

0.5-3 mg

Route

SubQ

OtherWell studied

ACTH 1-39

Corticotropin · Repository Corticotropin Injection · Acthar Gel

  • Stimulates the body's own cortisol production for conditions responsive to increased glucocorticoid activity
  • First-line option for infantile spasms in many treatment guidelines

As directed by your clinician

Dose

20-80 IU

Route

IM

CognitiveEmerging research

Adamax

  • Proposed nootropic and anxiolytic effects by analogy to related Semax-family peptides
  • Discussed informally for supporting attention and stress resilience

Morning

Dose

200-600 mcg

Route

SubQ

Weight LossEmerging research

Adipotide (FTPP)

FTPP · Fat-Targeted Proapoptotic Peptide

  • Rapid, substantial fat-mass reduction reported in primate studies
  • Mechanism distinct from appetite- or incretin-based weight agents

Morning

Dose

0.5-2 mg

Route

SubQ

OtherWell studied

Afamelanotide

Scenesse

  • Increases tolerance to sunlight and visible light exposure in EPP patients
  • Reduces frequency and severity of phototoxic reactions

As directed by your clinician

Dose

16-16 mg

Route

SubQ

SkinEmerging research

AHK-Cu

  • Studied for potential effects on VEGF expression relevant to hair follicle blood supply
  • Investigated for possible influence on dermal papilla cell activity linked to hair growth cycles

Evening

Dose

1-3 mg

Route

SubQ

MetabolicEmerging research

AICAR

Acadesine · 5-Aminoimidazole-4-carboxamide ribonucleotide

  • Studied in animal models for increased fatty acid oxidation
  • Explored for potential endurance and exercise-capacity effects

~30 min before exercise

Dose

250-500 mg

Route

SubQ

GHRPEmerging research

Alexamorelin

  • GH secretion observed in preclinical research
  • Studied for gastrointestinal motility support

~30 min before bed, empty stomach

Dose

50-150 mcg

Route

SubQ

Anti-InflamModerate evidence

Alpha-MSH

Alpha-Melanocyte-Stimulating Hormone

  • Studied for broad anti-inflammatory and immunomodulatory effects
  • Explored for skin pigmentation and photoprotection research

Morning

Dose

250-1,000 mcg

Route

SubQ

Weight LossModerate evidence

AOD-9604

HGH Fragment 176-191

  • Proposed to target fat metabolism without growth hormone's effect on blood sugar
  • Studied in human phase II obesity trials

Morning, empty stomach

Dose

250-500 mcg

Route

SubQ

Weight BlendsEmerging research

AOD-9604 / MOTS-c / Tesamorelin Blend

AMT Blend · AOD/MOTS-c/Tesa Blend

  • Tesamorelin has clinical trial evidence for visceral fat reduction in a specific approved indication
  • AOD-9604 is studied for direct lipolytic activity without the broader GH-axis stimulation associated with growth hormone secretagogues

Morning, before exercise

Dose

1-3 mg

Route

SubQ

HealingEmerging research

ARA-290

Cibinetide

  • Studied for neuropathic pain reduction in diabetic patients
  • Investigated for nerve fiber density support

Morning

Dose

1,000-4,000 mcg

Route

SubQ

SkinModerate evidence

Argireline

Acetyl Hexapeptide-3

  • Studied topically for reducing the appearance of expression lines
  • Proposed to modestly dampen muscle contraction signaling without full paralysis

Morning & night (topical)

Dose

5-15 mg

Route

SubQ

Weight LossEmerging research

BAM-15

  • Increased energy expenditure reported in animal studies
  • Resistance to diet-induced weight gain observed in preclinical models

Morning

Dose

25-100 mg

Route

Oral

OtherWell studied

Bivalirudin

Angiomax · Angiox

  • Provides effective procedural anticoagulation during PCI
  • Associated with reduced bleeding risk relative to some heparin plus GP IIb/IIIa inhibitor regimens in certain trials

As directed by your clinician

Dose

0.75-2.5 mg

Route

IV

HealingModerate evidence

BPC-157

Body Protection Compound-157

  • Studied for accelerated tendon and ligament repair in animal models
  • Investigated for gastrointestinal mucosal protection and ulcer healing

Morning, or split AM/PM

Dose

150-500 mcg

Route

SubQ

Healing BlendsWell studied

BPC-157 / TB-500 Blend

BPC-157/TB-500 Stack · Wolverine Blend

  • Supports tendon and ligament tissue repair in preclinical research
  • Associated with reduced local inflammation

Morning, or split AM/PM

Dose

250-750 mcg

Route

SubQ

Healing BlendsModerate evidence

BPC-157 15mg / TB-500 15mg Blend

High-Dose BPC/TB Blend · 30mg Recovery Vial

  • Supports tendon and ligament tissue repair in preclinical research
  • Associated with reduced local inflammation

Morning, or split AM/PM

Dose

0.3-1 mg

Route

SubQ

OtherEmerging research

Bronchogen

  • Proposed support for bronchial and respiratory tissue function in preliminary Russian research
  • Represents a short, simple peptide structure suggested to have a favorable safety profile in publications from its developers

Morning

Dose

50-200 mcg

Route

SubQ

OtherWell studied

Buserelin

Suprefact

  • Androgen suppression in prostate cancer
  • Reduction of endometriosis-related pain

As directed by your clinician

Dose

200-1,000 mcg

Route

SubQ

Weight LossModerate evidence

Cagrilintide

AM833

  • Associated with meaningful average weight loss as monotherapy in trials
  • Once-weekly dosing schedule

Weekly · same day, any time

Dose

0.3-4.5 mg

Route

SubQ

Weight LossModerate evidence

CagriSema (Cagrilintide + Semaglutide)

Cagrilintide/Semaglutide combination

  • Associated with greater average weight loss than semaglutide monotherapy in some trial comparisons
  • Combines two complementary satiety-signaling pathways

Weekly · same day, any time

Dose

0.25-2.4 mg

Route

SubQ

CognitiveWell studied

Cerebrolysin

  • Studied for supporting cognitive recovery after ischemic stroke
  • Explored as an adjunct in traumatic brain injury rehabilitation research

Morning

Dose

500-2,150 mg

Route

IM

GHRHModerate evidence

CJC-1295 (with DAC)

CJC-1295 · DAC:GRF

  • Sustained GH/IGF-1 elevation
  • Improved recovery and sleep quality

~30 min before bed, empty stomach

Dose

1,000-2,000 mcg

Route

SubQ

GHRHModerate evidence

CJC-1295 (without DAC / Mod GRF 1-29)

Mod GRF 1-29 · Modified GRF (1-29)

  • Natural pulsatile GH release
  • Improved recovery and sleep

~30 min before bed, empty stomach

Dose

100-300 mcg

Route

SubQ

GH BlendsWell studied

CJC-1295 / GHRP-2 Blend

  • Sustains elevated growth-hormone levels
  • Supports recovery

~30 min before bed, empty stomach

Dose

200-500 mcg

Route

SubQ

GH BlendsWell studied

CJC-1295 / GHRP-6 Blend

Bulking GH Blend

  • Stimulates a growth-hormone pulse
  • Pronounced appetite stimulation

~30 min before bed, empty stomach

Dose

200-500 mcg

Route

SubQ

GH BlendsWell studied

CJC-1295 / Ipamorelin Blend

CJC/Ipa Blend · GH Blend

  • Amplifies growth-hormone pulse compared with either component alone
  • Associated with improved recovery

~30 min before bed, empty stomach

Dose

200-500 mcg

Route

SubQ

SkinModerate evidence

Copper Peptide

  • Studied for supporting collagen and elastin synthesis in skin and connective tissue
  • Investigated for antioxidant and anti-inflammatory signaling properties

Evening

Dose

1-3 mg

Route

SubQ

CognitiveEmerging research

Cortagen

  • Proposed support for cortical neuron function in aging-related research
  • Explored within bioregulator theory as a tool for studying cognitive aging

Morning

Dose

1-3 mg

Route

SubQ

OtherWell studied

Degarelix

Firmagon

  • Rapid, castrate-level testosterone suppression
  • Avoids the initial tumor flare associated with GnRH agonists

As directed by your clinician

Dose

80-240 mg

Route

SubQ

CognitiveEmerging research

Dihexa

  • Preclinical models report potent effects on synapse formation at very low doses
  • Explored as a research tool for models of cognitive impairment

Morning

Dose

5-20 mcg

Route

SubQ

Cognitive BlendsEmerging research

Dihexa / Tesofensine Blend

Dihexa-Tesofensine Stack · DT Nootropic Blend

  • Tesofensine's monoamine reuptake inhibition is studied for increased alertness, motivation, and appetite suppression
  • Dihexa is studied preclinically for synaptogenesis and memory-related support

Morning

Dose

125-500 mcg

Route

SubQ

CognitiveEmerging research

DSIP (Delta Sleep-Inducing Peptide)

Delta Sleep-Inducing Peptide

  • Studied for potential support of delta-wave (deep) sleep in some research
  • Explored for stress-modulating and anti-anxiety properties

~30 min before bed

Dose

100-300 mcg

Route

SubQ

OtherWell studied

Dulaglutide

Trulicity

  • Improves HbA1c and fasting glucose control in type 2 diabetes
  • Once-weekly dosing supports treatment adherence

Weekly · same day, any time

Dose

0.75-4.5 mg

Route

SubQ

OtherWell studied

Elcatonin

  • Inhibits osteoclast-mediated bone resorption
  • May reduce bone pain associated with osteoporosis or vertebral compression

As directed by your clinician

Dose

10-40 IU

Route

IM

SexualModerate evidence

Enclomiphene

  • Studied for raising endogenous testosterone without suppressing natural production
  • May help preserve fertility and testicular function compared to exogenous testosterone

Morning, daily

Dose

6.25-25 mg

Route

Oral

OtherWell studied

Enfuvirtide

Fuzeon · T-20

  • Provides an additional mechanism of action for HIV-1 resistant to other antiretroviral classes
  • Can help achieve viral suppression in heavily treatment-experienced patients when combined with an optimized background regimen

Twice daily, evenly spaced

Dose

45-90 mg

Route

SubQ

LongevityEmerging research

Epithalon

Epitalon

  • May support healthy circadian rhythm and sleep patterns
  • Studied for potential telomerase-related cellular effects

Before bed

Dose

5-10 mg

Route

SubQ

OtherWell studied

Exenatide

Byetta · Bydureon · Exendin-4

  • Improves post-meal and fasting glucose control in type 2 diabetes
  • Glucose-dependent mechanism carries lower intrinsic hypoglycemia risk than sulfonylureas

Before meals

Dose

5-2,000 mcg

Route

SubQ

MuscleEmerging research

Follistatin 315

FST-315 · FS315

  • Proposed systemic reduction in myostatin/activin signaling
  • Suggested support for muscle mass preservation and growth in research models

Morning

Dose

100-300 mcg

Route

SubQ

MuscleEmerging research

Follistatin 344

FST-344 · FS344

  • Proposed reduction of myostatin-mediated suppression of muscle growth
  • Suggested support for satellite cell activation and muscle repair

Morning

Dose

100-300 mcg

Route

SubQ

LongevityEmerging research

FOXO4-DRI

  • Investigated in preclinical models for selective clearance of senescent cells
  • Studied as a potential approach to reduce senescence-associated inflammatory markers

Morning

Dose

2.5-10 mg

Route

SubQ

HealingWell studied

GHK-Cu

Copper Peptide GHK-Cu

  • Studied for stimulating collagen and elastin synthesis
  • Investigated for skin firmness and wrinkle appearance support

Evening

Dose

1-3 mg

Route

SubQ

GHRPWell studied

GHRP-2

Pralmorelin · KP-102

  • Increased GH/IGF-1 output
  • Improved recovery and sleep quality

~30 min before bed, empty stomach

Dose

100-300 mcg

Route

SubQ

GHRPWell studied

GHRP-6

GH-Releasing Hexapeptide

  • Strong appetite stimulation
  • Increased GH/IGF-1 output

~30 min before bed, empty stomach

Dose

100-300 mcg

Route

SubQ

Healing BlendsModerate evidence

GLOW Blend (BPC-157 + TB-500 + GHK-Cu)

GLOW Stack · Triple Healing Blend

  • Supports soft-tissue and connective-tissue repair
  • Studied for collagen production and skin quality

Morning, or split AM/PM

Dose

300-750 mcg

Route

SubQ

LongevityWell studied

Glutathione

  • May support antioxidant defense against oxidative stress
  • Studied for a role in liver detoxification pathways

Morning

Dose

200-1,200 mg

Route

IV

OtherWell studied

Gonadorelin

Factrel · Lutrepulse · GnRH

  • Assesses pituitary-gonadal axis function diagnostically
  • Helps maintain testicular size and endogenous testosterone/sperm production during TRT

As directed by your clinician

Dose

100-500 mcg

Route

SubQ

GHRPWell studied

Hexarelin

Examorelin

  • Strong acute GH release
  • Cardioprotective effects reported in research

~30 min before bed, empty stomach

Dose

50-200 mcg

Route

SubQ

GHWell studied

HGH (Human Growth Hormone)

Somatropin

  • Studied for growth hormone deficiency treatment
  • Investigated for body composition changes, including fat reduction and lean mass support

~30 min before bed, empty stomach

Dose

2-8 IU

Route

SubQ

LongevityEmerging research

Humanin

  • Studied for potential neuroprotective effects against oxidative and beta-amyloid stress
  • Explored for roles in mitochondrial and metabolic health

Morning

Dose

1-4 mg

Route

SubQ

OtherWell studied

Icatibant

Firazyr

  • Allows rapid, self-administered treatment of acute HAE attacks outside a hospital setting
  • Directly targets the bradykinin pathway responsible for HAE swelling

As needed, during an attack

Dose

30-90 mg

Route

SubQ

MuscleEmerging research

IGF-1 DES

Des(1-3) IGF-1 · DES IGF-1

  • High potency at the IGF-1 receptor per unit dose
  • Proposed localized hypertrophic effect at the injection site

~20 min before a workout

Dose

20-60 mcg

Route

IM

MuscleEmerging research

IGF-1 LR3

Long R3 IGF-1 · LR3 IGF-1

  • Reported support for lean tissue accrual when combined with resistance training
  • Proposed enhancement of nutrient partitioning toward muscle over fat

After a workout

Dose

20-60 mcg

Route

SubQ / IM

GHRPModerate evidence

Ipamorelin

NNC 26-0161

  • Selective GH release with minimal off-target effects
  • Improved sleep quality

~30 min before bed, empty stomach

Dose

100-300 mcg

Route

SubQ

SexualModerate evidence

Kisspeptin-10

  • Studied for stimulating the hypothalamic-pituitary-gonadal axis
  • Investigated as a research tool for reproductive hormone regulation

As directed by your clinician

Dose

50-200 mcg

Route

SubQ

Healing BlendsEmerging research

KLOW Blend (BPC-157 + TB-500 + GHK-Cu + KPV)

KLOW Stack · Quad Healing Blend

  • Supports soft-tissue and connective-tissue repair
  • Studied for anti-inflammatory activity in preclinical gut and skin models

Morning, or split AM/PM

Dose

350-800 mcg

Route

SubQ

Anti-InflamEmerging research

KPV

  • Studied in animal models of colitis and inflammatory bowel disease
  • Explored for skin-related inflammatory conditions

Morning, or split AM/PM

Dose

200-1,000 mcg

Route

SubQ

Weight LossWell studied

L-Carnitine

Levocarnitine

  • Modest reductions in body weight and fat mass reported in meta-analyses
  • May support exercise recovery and reduce exercise-induced muscle damage

~30 min before exercise

Dose

500-2,000 mg

Route

Oral

OtherWell studied

Lanreotide

Somatuline

  • Normalizes GH and IGF-1 levels in acromegaly
  • Controls flushing and diarrhea in carcinoid/neuroendocrine tumor syndromes

As directed by your clinician

Dose

60-120 mg

Route

SubQ

SkinEmerging research

Lemon Bottle

  • Marketed for localized reduction of small subcutaneous fat deposits
  • Used in aesthetic clinic settings as a spot-treatment alternative to surgical procedures

As directed by your provider

Dose

2-6 mg

Route

SubQ

OtherWell studied

Leuprolide

Leuprorelin · Lupron · Eligard

  • Androgen deprivation therapy in advanced/metastatic prostate cancer
  • Symptom control in endometriosis and uterine fibroids

As directed by your clinician

Dose

3.75-45 mg

Route

IM

OtherWell studied

Liraglutide

Victoza · Saxenda

  • Improves glycemic control (HbA1c reduction) in type 2 diabetes
  • Promotes clinically meaningful weight loss at higher, weight-management-labeled doses

Daily · same time, any time

Dose

0.6-3 mg

Route

SubQ

Anti-InflamModerate evidence

LL-37

  • Studied for broad-spectrum antimicrobial defense
  • Explored for supportive roles in wound healing and tissue repair

Morning

Dose

50-200 mcg

Route

SubQ

SkinModerate evidence

Matrixyl

Palmitoyl Pentapeptide-4

  • Studied topically for supporting collagen I, III, and IV synthesis
  • Investigated for potential support of fibronectin and glycosaminoglycan production

Morning & night (topical)

Dose

5-15 mg

Route

SubQ

Weight LossModerate evidence

Mazdutide

IBI362 · LY3305677

  • Associated with meaningful average weight loss in clinical trials
  • May improve glycemic control

Weekly · same day, any time

Dose

3-9 mg

Route

SubQ

SkinModerate evidence

Melanotan I

Afamelanotide (related)

  • Produces a sunless tan by boosting the skin’s own melanin
  • More pigmentation-selective than Melanotan II, with less appetite or libido effect

Before sun exposure

Dose

250-1,000 mcg

Route

SubQ

SexualModerate evidence

Melanotan II

  • Studied for stimulating melanogenesis, producing a tanning effect without prolonged UV exposure
  • Reported secondary effects on libido in some users and small studies

Evening

Dose

250-1,000 mcg

Route

SubQ

MetabolicModerate evidence

Methylene Blue

Methylthioninium Chloride

  • Explored for potential mitochondrial and cellular energy support at low doses
  • Established clinical use for methemoglobinemia at higher, medically supervised doses

Morning

Dose

5-30 mg

Route

Oral

MuscleEmerging research

MGF (Mechano Growth Factor)

IGF-1Ec · Mechano Growth Factor

  • Proposed activation of satellite cells following mechanical muscle damage
  • Suggested support for localized post-exercise muscle repair

After a workout

Dose

200-600 mcg

Route

IM

Weight LossEmerging research

MOTS-c

  • May support insulin sensitivity based on preclinical research
  • Proposed role in mitochondrial energy metabolism

~30 min before a workout

Dose

5-10 mg

Route

SubQ

MuscleEmerging research

Myostatin Inhibitor (GDF-8)

GDF-8 inhibitor

  • Proposed reduction of a key natural brake on skeletal muscle growth
  • Rationale supported by naturally occurring myostatin-deficient animal and rare human cases showing pronounced muscularity

Morning

Dose

100-300 mcg

Route

SubQ / IM

CognitiveModerate evidence

NA-Selank

N-Acetyl Selank

  • Proposed longer duration of action compared with standard Selank
  • Explored for anxiolytic effects without apparent sedation

Morning

Dose

250-750 mcg

Route

SubQ

CognitiveModerate evidence

NA-Semax

N-Acetyl Semax

  • Proposed extended duration of action compared with standard Semax
  • Explored for potential effects on attention and short-term memory

Morning

Dose

200-600 mcg

Route

SubQ

MetabolicModerate evidence

NAD+

Nicotinamide Adenine Dinucleotide

  • Supports mitochondrial ATP production as a required metabolic cofactor
  • Investigated for roles in DNA repair via PARP and sirtuin pathways

Morning

Dose

50-200 mg

Route

SubQ

OtherWell studied

Nafarelin

Synarel

  • Reduces endometriosis-associated pelvic pain
  • Suppresses premature pubertal development in central precocious puberty

As directed by your clinician

Dose

400-800 mcg

Route

Nasal

MetabolicModerate evidence

NMN (Nicotinamide Mononucleotide)

Nicotinamide Mononucleotide

  • Studied for potential support of insulin sensitivity in early human trials
  • Explored for vascular and cardiovascular metabolic markers

Morning

Dose

125-500 mg

Route

SubQ

OtherWell studied

Octreotide

Sandostatin

  • Controls growth hormone excess in acromegaly
  • Reduces flushing and diarrhea in carcinoid syndrome

As directed by your clinician

Dose

50-500 mcg

Route

SubQ

Weight LossModerate evidence

Orforglipron

LY3502970

  • Oral administration avoids the need for injections
  • Associated with meaningful average weight loss in late-stage trials

Morning, empty stomach

Dose

3-36 mg

Route

Oral

OtherWell studied

Oxytocin

Pitocin · Syntocinon

  • Induces or augments labor contractions
  • Reduces postpartum hemorrhage by promoting uterine contraction

As directed by your clinician

Dose

0.001-0.02 IU

Route

IV

OtherWell studied

Oxytocin Acetate

Oxytocin · Pitocin · Syntocinon

  • Approved and well-established for inducing or augmenting labor in obstetric care
  • Approved for controlling postpartum hemorrhage

As directed by your clinician

Dose

5-20 IU

Route

SubQ

SkinEmerging research

Palmitoyl Pentapeptide

  • Studied in topical research for supporting extracellular matrix and collagen-related signaling
  • Explored for potential roles in tissue repair processes

Morning & night (topical)

Dose

5-15 mg

Route

SubQ

OtherWell studied

Pasireotide

Signifor

  • Reduces cortisol excess in Cushing's disease
  • Normalizes GH and IGF-1 in acromegaly

Twice daily (AM & PM)

Dose

300-900 mcg

Route

SubQ

MuscleEmerging research

PEG-MGF

Pegylated MGF

  • Proposed sustained activation of satellite cells involved in muscle repair
  • Extended systemic half-life compared with unmodified MGF

After a workout

Dose

200-600 mcg

Route

SubQ

Weight LossModerate evidence

Pemvidutide

ALT-801

  • Associated with meaningful average weight loss in early-phase trials
  • May reduce liver fat content

Weekly · same day, any time

Dose

1.2-2.4 mg

Route

SubQ

HealingEmerging research

Pentadecapeptide

PL 14736 · BPC 15

  • Studied for gastric and intestinal mucosal protection
  • Investigated for support of ulcer healing in animal models

Morning, or split AM/PM

Dose

200-500 mcg

Route

SubQ

CognitiveEmerging research

Pinealon

  • Proposed support for sleep-wake cycle regulation in preliminary research
  • Explored for antioxidant activity in central nervous system tissue

Before bed

Dose

1-3 mg

Route

SubQ

OtherEmerging research

PNC-27

  • Proposed selective cytotoxic activity against cancer cells in preclinical laboratory studies
  • Investigated mechanism distinct from conventional chemotherapy, potentially relevant to future research

As directed by your clinician

Dose

250-1,000 mcg

Route

SubQ

OtherWell studied

Pramlintide

Symlin

  • Reduces post-meal blood glucose spikes when added to mealtime insulin
  • Associated with modest reductions in body weight in clinical studies

Before meals

Dose

15-120 mcg

Route

SubQ

SexualWell studied

PT-141 (Bremelanotide)

Bremelanotide

  • Studied for supporting sexual desire and arousal in individuals with hypoactive sexual desire disorder
  • Acts via central nervous system pathways rather than vascular mechanisms

~45 min before activity

Dose

500-1,750 mcg

Route

SubQ

Weight LossModerate evidence

Retatrutide

LY3437943

  • Associated with substantial reductions in body weight in clinical trial participants
  • May improve markers of glycemic control

Weekly · same day, any time

Dose

2-12 mg

Route

SubQ

OtherWell studied

Romiplostim

Nplate

  • Increases and sustains platelet counts in chronic ITP resistant to first-line therapy
  • Reduces the need for rescue therapies (corticosteroids, immunoglobulins) in responders

Weekly · clinician-directed

Dose

1-10 mcg

Route

SubQ

OtherWell studied

Salmon Calcitonin

Miacalcin · Fortical · Calcitonin-salmon

  • Lowers elevated serum calcium in hypercalcemia of malignancy
  • Reduces bone turnover markers and can relieve bone pain in Paget's disease

As directed by your clinician

Dose

50-200 IU

Route

SubQ

CognitiveWell studied

Selank

  • Studied for anxiolytic effects without apparent sedation
  • Explored for mild nootropic effects on attention and mental stamina

Morning

Dose

250-750 mcg

Route

SubQ

Cognitive BlendsEmerging research

Selank / Semax Blend

Selank-Semax Stack · SS Cognitive Blend

  • Studied components are individually associated with reduced anxiety-like behavior (Selank) and support for memory and attention (Semax)
  • Delivered as a single combined injection rather than two separate peptides

Morning

Dose

150-600 mcg

Route

SubQ

Weight LossWell studied

Semaglutide

Ozempic · Wegovy · Rybelsus

  • Associated with significant average body-weight reduction in clinical trials
  • Improves glycemic control in type 2 diabetes

Weekly · same day, any time

Dose

0.25-2.4 mg

Route

SubQ

CognitiveWell studied

Semax

  • Associated in research with improved attention and short-term memory performance
  • Studied for potential neuroprotective effects following cerebral ischemia

Morning

Dose

200-600 mcg

Route

SubQ

GHRHWell studied

Sermorelin

GRF(1-29) · Geref

  • Restores a more natural pulsatile GH release
  • Improved sleep quality

~30 min before bed, empty stomach

Dose

200-500 mcg

Route

SubQ

GH BlendsWell studied

Sermorelin / GHRP-2 Blend

Classic GH Blend

  • Stimulates growth-hormone pulse via two distinct pathways
  • Long individual research history for both components

~30 min before bed, empty stomach

Dose

200-500 mcg

Route

SubQ

GH BlendsModerate evidence

Sermorelin / GHRP-6 / GHRP-2 Blend

Triple Secretagogue Blend

  • Stimulates a strong growth-hormone pulse
  • Associated with pronounced appetite stimulation, useful in mass-gain-oriented research contexts

~30 min before bed, empty stomach

Dose

300-700 mcg

Route

SubQ

SkinModerate evidence

Snap-8

Acetyl Octapeptide-3

  • Studied topically for reducing the appearance of forehead expression lines
  • Proposed to extend the mechanism of related peptide Argireline

Morning & night (topical)

Dose

5-15 mg

Route

SubQ

LongevityWell studied

SS-31

Elamipretide · Bendavia · MTP-131

  • Studied for support of mitochondrial energy production under stress
  • Investigated in clinical trials for heart failure and mitochondrial myopathy

Morning, same time daily

Dose

20-60 mg

Route

SubQ

Weight LossModerate evidence

Survodutide

BI 456906

  • Associated with meaningful average weight loss in phase 2 trials
  • May reduce liver fat content in studied populations

Weekly · same day, any time

Dose

0.6-6 mg

Route

SubQ

SkinEmerging research

SYN-AKE

  • Studied topically for reducing the appearance of expression wrinkles
  • Proposed to act through a distinct receptor mechanism from botulinum toxin and other cosmetic peptides

Morning & night (topical)

Dose

2-8 mg

Route

SubQ

HealingModerate evidence

TB-500 (Thymosin Beta-4)

Thymosin Beta-4 · TB4

  • Studied for systemic wound healing support
  • Investigated for angiogenesis promotion in damaged tissue

Morning

Dose

2-5 mg

Route

SubQ

GHRHWell studied

Tesamorelin

Egrifta · TH9507

  • Clinically demonstrated reduction in visceral adipose tissue
  • Increases IGF-1

~30 min before bed, empty stomach

Dose

1-3 mg

Route

SubQ

GH BlendsModerate evidence

Tesamorelin / CJC-1295 / Ipamorelin Blend

Triple GH Blend

  • Aims to amplify and extend growth-hormone pulse coverage
  • Supports body composition research

~30 min before bed, empty stomach

Dose

1,500-3,200 mcg

Route

SubQ

GH BlendsWell studied

Tesamorelin / Ipamorelin Blend

Tesa/Ipa Blend

  • Associated with visceral fat reduction based on tesamorelin's studied effects
  • Supports body composition changes

~30 min before bed, empty stomach

Dose

1,500-3,000 mcg

Route

SubQ

GH BlendsEmerging research

Tesamorelin / MGF / Ipamorelin Blend

Tesa/MGF/Ipa Blend

  • Systemic growth-hormone axis stimulation
  • Proposed local muscle-repair signaling from the MGF component

~30 min before bed, empty stomach

Dose

1,000-2,500 mcg

Route

SubQ

Weight LossModerate evidence

Tesofensine

NS2330

  • Associated with appetite reduction and body-weight loss in early clinical trials
  • Oral administration

Morning

Dose

0.25-1 mg

Route

Oral

LongevityWell studied

Thymosin Alpha-1

Tα1 · Zadaxin

  • May support immune resilience during chronic infection or immunosuppression
  • Studied as an adjunct in some chronic viral hepatitis protocols

Morning

Dose

800-1,600 mcg

Route

SubQ

Anti-InflamModerate evidence

Thymulin

  • Studied for support of T-lymphocyte differentiation and thymic function
  • Explored in research on age-related immune decline (immunosenescence)

Morning

Dose

100-400 mcg

Route

SubQ

Weight LossWell studied

Tirzepatide

LY3298176 · Mounjaro · Zepbound

  • Associated with significant average body-weight reduction in clinical trials
  • Improves glycemic control in type 2 diabetes

Weekly · same day, any time

Dose

2.5-15 mg

Route

SubQ

OtherWell studied

Triptorelin

Decapeptyl · Trelstar · Diphereline

  • Androgen deprivation for advanced prostate cancer
  • Suppresses estrogen-driven pain in endometriosis

As directed by your clinician

Dose

3.75-22.5 mg

Route

IM

OtherModerate evidence

Vapreotide

Sanvar

  • Studied for reduction of acute variceal hemorrhage
  • Investigated for control of neuroendocrine tumor-related secretory symptoms

As directed by your clinician

Dose

50-100 mcg

Route

SubQ

Anti-InflamModerate evidence

VIP (Vasoactive Intestinal Peptide)

Vasoactive Intestinal Peptide

  • Studied in chronic inflammatory response syndrome and mold-illness protocols
  • Explored for anti-inflammatory immune modulation

As directed by your clinician

Dose

25-100 mcg

Route

SubQ

Healing BlendsModerate evidence

VIP + BPC-157 Blend

VIP/BPC Stack

  • Studied for gut-lining and mucosal support
  • Associated with broad anti-inflammatory and immune-modulating activity

Morning, or split AM/PM

Dose

200-500 mcg

Route

SubQ

OtherWell studied

Ziconotide

Prialt · SNX-111 · Omega-conotoxin MVIIA

  • Provides an opioid-free option for severe, treatment-refractory chronic pain
  • Does not appear to cause tolerance or physical dependence with continued use

As directed by your clinician

Dose

2.4-21.6 mcg

Route

IV

Partner offer · $20 off

When did you last
check your blood work?

Regular blood work catches changes early. At-home collection with free pickup, 50+ biomarkers, and results in 72 hours.

  1. 1Order your kitTakes two minutes online, $20 off with this link.
  2. 2Collect at homePainless draw with free home pickup, no lab visit.
  3. 3Results in 72 hours50+ biomarkers with clear optimal ranges.
Get my blood test — $20 off

Partner offer · opens rythm.health

Latest from Learn

View all →

Laboratory research use only

All compounds and information on this site are intended strictly for laboratory research and educational use only. They are not for human or veterinary use.

The statements on this website have not been evaluated by the U.S. Food and Drug Administration. Nothing on this site is intended to diagnose, treat, cure, or prevent any disease.

Educational use only. The information and calculators on this site are provided for research and educational purposes and are not medical advice, a diagnosis, a prescription, or a substitute for a licensed healthcare provider. Many compounds described are research compounds or prescription medicines not approved for general use. You must be 21 or older. Always consult a qualified clinician before making any health decision. Read the full disclaimer · Privacy Policy

© 2026 LifeConverted. All rights reserved.

Not for human or veterinary use.

Powered with by Plondo